Inhibiting coronavirus 5' RNA capping with potent, selective, FIC small molecules, May 2024, 4th SCI / RSC Symposium on Anti-Infectives Drug Discovery

Angela Glen¹ , Byron Andrews¹ , Ralph Baric^2a, Elliot Bayle¹ , Caitlin Duncan¹ , Matthew Fyfe¹ , Patrick Guest¹ , Helen Harrison¹ , Mark Heise^2b, Nat Moorman^2c, Oliver Rausch¹ , Trevor Scobey^2a, Tim Sheahan^2a, Chris Swain¹ , Sharon Taft-Benz^2b, Beth Thomas¹ , Aleksandra Zemla-Brown¹

¹STORM Therapeutics Ltd, Babraham Research Campus, Cambridge CB22 3AT, United Kingdom

²AViDD-READDI, Rapidly Emerging Antiviral Drug Development Initiative (READDI): a) Department of Epidemiology, UNC Chapel Hill, Gillings School of Public Health; b) Department of Genetics, UNC Chapel Hill, School of Medicine; c) Department of Microbiology and Immunology, UNC Chapel Hill, School of Medicine

Download poster